Target intelligence / Profile preview

G1 to S phase transition protein 1 homolog (GSPT1)

Target
GSPT1
Molecular classification
GTPase, Translation termination factor, Enzyme
01

Overview

G1 to S phase transition protein 1 homolog (GSPT1), also known as eRF3a, is a GTPase that plays a fundamental role in eukaryotic protein translation termination. It forms a complex with eRF1 to recognize stop codons and facilitate the release of nascent polypeptide chains from the ribosome (UniProt P15170). Beyond translation, GSPT1 is involved in regulating the transition of cells from the G1 to the S phase of the cell cycle and contributes to the control of mRNA stability. In recent years, GSPT1 has gained significant attention as a therapeutic target in oncology, particularly for acute myeloid leukemia (AML), due to its susceptibility to targeted protein degradation. Molecular glue degraders, such as CC-90009, recruit GSPT1 to the CRL4-CRBN E3 ubiquitin ligase complex, leading to its polyubiquitination and subsequent proteasomal degradation, which triggers rapid apoptosis in MYC-driven cancer cells (Surka et al., 2021, Nature Communications).

Other names
eRF3aEukaryotic peptide chain release factor GTP-binding subunit 3aG1 to S phase transition 1GST1
02

Mechanism of action

Targeted protein degradation via molecular glue recruitment to the CRL4-CRBN E3 ubiquitin ligase complex.

03

Biological functions

Translation terminationCell cycle regulationmRNA stabilityApoptosis regulation
04

Disease associations

CancerAcute myeloid leukemiaSolid tumors
05

Safety considerations

Hematological toxicityNeutropeniaPotential for off-target degradation of related translation factors
06

Interacting drugs

CC-90009 (BMS-986357)

2 more in the full profile.

07

Biomarkers

GSPT1 protein expression levelsCRBN (Cereblon) expressionMYC expression levels

Beyond the preview

Go deeper on G1 to S phase transition protein 1 homolog (GSPT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G1 to S phase transition protein 1 homolog (GSPT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call